|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| OGEN | Frederick W. Telling | Director | Dec 12 '25 | Proposed Sale | 0.91 | 210 | 192 | Dec 12 06:28 PM | |
| OGEN | Telling Fred | Director | Dec 06 '24 | Sale | 0.36 | 3,597 | 1,295 | 34,748 | Dec 09 04:23 PM |
| OGEN | Frederick Telling | Director | Dec 06 '24 | Proposed Sale | 0.36 | 3,597 | 1,294 | Dec 06 04:35 PM | |
| OGEN | Telling Fred | Director | Nov 30 '23 | Sale | 3.57 | 3,500 | 12,488 | 38,345 | Dec 01 05:23 PM |
| OGEN | Telling Fred | Director | Jun 17 '22 | Buy | 0.29 | 10,084 | 2,884 | 1,010,000 | Jun 21 09:30 AM |
| OGEN | Telling Fred | Director | May 23 '22 | Buy | 0.29 | 3,500 | 1,004 | 921,243 | May 25 04:05 PM |
| OGEN | Telling Fred | Director | May 24 '22 | Buy | 0.29 | 78,673 | 22,776 | 999,916 | May 25 04:05 PM |
| OGEN | Telling Fred | Director | May 20 '22 | Buy | 0.28 | 65,718 | 18,638 | 917,743 | May 23 04:15 PM |
| OGEN | Telling Fred | Director | May 18 '22 | Buy | 0.26 | 15,303 | 3,994 | 795,219 | May 20 04:15 PM |
| OGEN | Telling Fred | Director | May 19 '22 | Buy | 0.28 | 56,806 | 15,945 | 852,025 | May 20 04:15 PM |
| OGEN | Telling Fred | Director | Mar 30 '22 | Buy | 0.36 | 124,785 | 45,284 | 720,863 | Apr 01 04:05 PM |
| OGEN | Telling Fred | Director | Mar 31 '22 | Buy | 0.35 | 59,053 | 20,769 | 779,916 | Apr 01 04:05 PM |
| OGEN | Telling Fred | Director | Nov 24 '20 | Buy | 0.37 | 100,000 | 37,000 | 439,538 | Nov 25 04:05 PM |
| OGEN | Telling Fred | Director | Jun 30 '16 | Buy | 0.52 | 969,180 | 500,000 | 1,315,354 | Jul 01 04:05 PM |
| OGEN | Telling Fred | Director | Nov 14 '14 | Buy | 0.95 | 27,000 | 25,541 | 266,174 | Nov 17 04:06 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite